Quest Diagnostics, Inc (NYSE: DGX) is 16.58% higher on its value in year-to-date trading and has touched a low of $134.05 and a high of $178.87 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DGX stock was last observed hovering at around $173.57 in the last trading session, with the day’s gains setting it 2.3%.
Currently trading at $175.87, the stock is 5.37% and 3.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.57 million and changing 1.33% at the moment leaves the stock 11.63% off its SMA200. DGX registered 35.19% gain for a year compared to 6-month gain of 19.34%. The firm has a 50-day simple moving average (SMA 50) of $169.1644 and a 200-day simple moving average (SMA200) of $157.55235.
The stock witnessed a 6.16% loss in the last 1 month and extending the period to 3 months gives it a 15.82%, and is 6.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.98% over the week and 3.15% over the month.
Quest Diagnostics, Inc (DGX) has around 56000 employees, a market worth around $19.63B and $10.16B in sales. Current P/E ratio is 22.23 and Fwd P/E is 16.68. Profit margin for the company is 8.78%. Distance from 52-week low is 31.20% and -1.68% from its 52-week high. The company has generated returns on investments over the last 12 months (6.69%).
with sales reaching $2.72B over the same period.The EPS is expected to grow by 8.64% this year, but quarterly earnings will post 9.25% year-over-year. Quarterly sales are estimated to grow 13.51% in year-over-year returns.
1294.0 institutions hold shares in Quest Diagnostics, Inc (DGX), with institutional investors hold 93.68% of the company’s shares. The shares outstanding are 112.00M, and float is at 111.03M with Short Float at 2.57%. Institutions hold 93.30% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.95 million shares valued at $1.91 billion. The investor’s holdings represent 12.5692 of the DGX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 10.06 million shares valued at $1.38 billion to account for 9.0625 of the shares outstanding. The other top investors are STATE STREET CORP which holds 5.19 million shares representing 4.6781 and valued at over $710.77 million, while VICTORY CAPITAL MANAGEMENT INC holds 3.4988 of the shares totaling 3.88 million with a market value of $531.6 million.
Quest Diagnostics, Inc (DGX) Insider Activity
The most recent transaction is an insider sale by Davis J. E., the company’s CEO and President. SEC filings show that Davis J. E. sold 39,191 shares of the company’s common stock on Apr 02 ’25 at a price of $168.46 per share for a total of $6.6 million. Following the sale, the insider now owns 0.13 million shares.
Quest Diagnostics, Inc disclosed in a document filed with the SEC on Apr 02 ’25 that KUPPUSAMY KARTHIK (SVP, Clinical Solutions) sold a total of 2,555 shares of the company’s common stock. The trade occurred on Apr 02 ’25 and was made at $170.00 per share for $0.43 million. Following the transaction, the insider now directly holds 10575.0 shares of the DGX stock.
Still, SEC filings show that on Apr 02 ’25, Davis J. E. (Officer) Proposed Sale 39,191 shares at an average price of $170.00 for $6.66 million. The insider now directly holds shares of Quest Diagnostics, Inc (DGX).
